TrialJournal of thrombosis and haemostasis : JTH2021

Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: A multi-center, open-label, randomized controlled trial.

Usha S Perepu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.